Ready 8-Ks
50
Latest filing
August 25, 2026, 4:38 PM ET
Top materiality
0.90
Event mix
earnings ×14 · leadership ×13 · other_material ×7
Sentiment
9 pos · 2 neg · 39 neu
Latest earnings
reported 2026-Q1
-
Exelon Reports First Quarter 2026 Adjusted Earnings of $0.91 Per Share, Affirms Full-Year Guidance
GAAP net income of $0.90 per share and adjusted operating earnings of $0.91 per share for Q1 2026.
-
Exelon subsidiary PECO withdraws rate case filings; Maryland utility regulation changes
PECO withdrew electric and gas rate filings with PA PUC, citing customer affordability; delays grid modernization investments.
-
Exelon Q4 adj EPS $0.59 vs $0.64 YoY; FY25 $2.77; FY26 guide $2.81-$2.91
Q4 2025 GAAP EPS $0.58, adj EPS $0.59; full-year adj EPS $2.77 ($2.50 YoY).
-
Exelon derivative settlement gets preliminary court approval; $40M insurance payout, governance reforms
Preliminary approval granted Nov 18, 2025 for consolidated derivative settlement related to ComEd bribery scheme.
-
Exelon Q3 adjusted EPS $0.86, up from $0.71; reaffirms FY2025 guidance $2.64-$2.74
GAAP EPS $0.86, adjusted EPS $0.86 in Q3 2025 vs. $0.70/$0.71 year ago; net income $875M, up $168M.
-
Exelon Q2 adjusted EPS $0.39, down from $0.47 YoY; reaffirms FY guidance $2.64-2.74
GAAP net income $391M ($0.39/diluted) vs $448M ($0.45) in Q2 2024; adjusted operating earnings $392M ($0.39) vs $472M ($0.47).
-
Exelon Q1 adjusted EPS $0.92, reaffirms FY2025 guidance $2.64-$2.74
GAAP EPS $0.90, adjusted EPS $0.92 for Q1 2025, up from $0.66 and $0.68 YoY.
-
Exelon issues $1.0B in notes to repay $464M commercial paper; rates 5.125% (2031) and 5.875% (2055)
Issued $500M 5.125% notes due 2031 and $500M 5.875% notes due 2055.
-
Exelon Q4 adjusted EPS $0.64; initiates 2025 guidance $2.64-$2.74; raises 4-yr capex to $38B
Q4 2024 GAAP net income $0.64 per share; adjusted (non-GAAP) $0.64 per share, up from $0.60 in Q4 2023.
-
Exelon Q3 2024 adj EPS $0.71 vs $0.67; reaffirms FY2024 guidance $2.40-$2.50
GAAP net income $0.70/sh; adjusted operating EPS $0.71 (up from $0.67); FY2024 guidance reaffirmed at $2.40-$2.50; 5-7% EPS growth target through 2027 reaffirmed.
-
Exelon Q2 adjusted EPS $0.47 beats prior year; reaffirms FY2024 outlook
GAAP EPS $0.45; adjusted EPS $0.47 vs $0.41 in Q2 2023.
-
Exelon Q1 adjusted EPS $0.68 vs $0.70 YoY; reaffirms FY guidance $2.40-$2.50
GAAP EPS $0.66 vs $0.67 Q1 2023; adjusted $0.68 vs $0.70; reaffirms full-year $2.40-$2.50 range.
-
Exelon Q4 adjusted EPS $0.60 vs $0.43 YoY; 2024 guidance $2.40-$2.50; dividend raised 5.6%
Q4 adjusted EPS $0.60 (GAAP $0.62) from $0.43 prior year; full-year 2023 adjusted EPS $2.38 (GAAP $2.34).
-
Exelon promotes Mike Innocenzo to COO; Dave Velazquez to lead PECO; CHRO succession
Mike Innocenzo becomes Exelon EVP & COO effective April 1, 2024; base salary $685k, LTI target $1.765M.
-
ComEd gets ~$450M 2024 rate hike vs $968M requested; BGE rates cut; Exelon reaffirms EPS guidance
ICC order grants ComEd ~$450M 2024 rate increase versus $968M requested; ROE set at 8.905% vs requested 10.50-10.65%.
-
Exelon reports Q3 adjusted EPS $0.67, down from $0.75 YoY; narrows FY guidance to $2.32-$2.40
GAAP EPS $0.70; adjusted (non-GAAP) EPS $0.67, vs $0.75 a year ago.
-
Exelon reaches $40M derivative settlement over ComEd bribery allegations; court approval pending
Settlement includes $40M payment from insurers to Exelon; $10M allocated for plaintiffs' attorneys' fees.
-
Exelon Q1 adjusted EPS $0.70 beats prior year $0.64; reaffirms FY guidance
GAAP EPS $0.67; adjusted (non-GAAP) operating EPS $0.70, up from $0.64 YoY.
-
Exelon Q4 adj EPS $0.43, up from $0.39 YoY; guides 2023 $2.30-$2.42; dividend raised 6.7%
Q4 2022 GAAP EPS $0.43, adjusted EPS $0.43; full-year adjusted EPS $2.27 vs $1.83 in 2021.
-
ComEd expected to get new Chicago franchise; $90M equity fund proposed
New franchise license would have initial 15-year term ending Dec 31, 2037, with 5-year extension option.
-
ComEd files 2024-2027 rate plan with ICC; seeks $3.8-4.4B annual revenue
Proposed base rate revenue: $3.76B (2024), $3.93B (2025), $4.15B (2026), $4.35B (2027).